Torin-1 - Revision history

Prab: CSV import

2025-02-13T03:45:17Z

CSV import

← Older revision		Revision as of 03:45, 13 February 2025
Line 1:		Line 1:
	== Torin-1 ==		== Torin-1 ==

	[[File:Torin1_structure.png\|thumb\|Chemical structure of Torin-1]]		[[File:Torin1_structure.png\|thumb\|right\|Chemical structure of Torin-1]]

	'''Torin-1''' is a potent and selective inhibitor of the [[mammalian target of rapamycin]] (mTOR), a ~~protein~~ kinase ~~that plays a critical role~~ in ~~regulating~~ cell growth, proliferation, and survival. It is widely used in [[biological research]] to study the mTOR signaling pathway.		'''Torin-1''' is a potent and selective inhibitor of the [[mammalian target of rapamycin]] (mTOR), a key regulatory kinase involved in cell growth, proliferation, and survival. It is widely used in [[biological research]] to study the mTOR signaling pathway and its role in various cellular processes.

	== Mechanism of Action ==		== Mechanism of Action ==

	Torin-1 ~~inhibits~~ both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)~~. By targeting these complexes, Torin-1 effectively blocks the downstream signaling pathways that are involved in cell growth and metabolism~~. This dual inhibition is significant because mTORC1 and mTORC2 regulate different aspects of cellular ~~function~~, ~~and their combined inhibition can lead to more comprehensive suppression of~~ mTOR signaling.		Torin-1 functions by inhibiting both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). This dual inhibition is significant because mTORC1 and mTORC2 regulate different aspects of cellular metabolism and growth. By targeting both complexes, Torin-1 effectively suppresses mTOR signaling, leading to reduced protein synthesis and cell proliferation.

	== Applications in Research ==		== Applications in Research ==

	Torin-1 is primarily used in [[cancer research]] to ~~explore~~ the role of mTOR in tumor growth and progression. It has been shown to induce autophagy, a process ~~where cells degrade and recycle their components~~, ~~which can be beneficial in understanding cancer cell survival mechanisms~~. ~~Additionally, Torin-1 is used to study [[neurodegenerative diseases]], as~~ mTOR signaling ~~is implicated in the regulation of neuronal survival~~ and ~~function~~.		Torin-1 is primarily used in [[cancer research]] to investigate the role of mTOR in tumor growth and progression. It has been shown to induce [[autophagy]], a cellular degradation process, by inhibiting mTORC1. This property makes it a valuable tool for studying the interplay between mTOR signaling and autophagy.

	~~== Synthesis~~ and ~~Chemical Properties ==~~		In addition to cancer research, Torin-1 is used to explore mTOR's involvement in [[metabolic disorders]], [[neurodegenerative diseases]], and [[aging]]. Its ability to modulate mTOR activity provides insights into the potential therapeutic applications of mTOR inhibitors.

	~~The chemical structure of~~ Torin-1 is ~~characterized by its unique arrangement of atoms that allow it to bind effectively to~~ the ~~mTOR kinase domain~~. ~~The synthesis of Torin-1 involves multiple steps of organic chemistry, ensuring~~ high specificity and potency~~. Its chemical properties, such as solubility and stability~~, ~~make~~ it ~~suitable for use~~ in ~~various~~ experimental ~~conditions~~.		== Chemical Properties ==

			Torin-1 is a small molecule with a complex chemical structure, as depicted in the image on the right. Its design allows for high specificity and potency in inhibiting mTOR, making it a preferred choice in experimental settings.

	== Safety and Handling ==		== Safety and Handling ==

	As with many chemical inhibitors, proper safety protocols ~~must~~ be followed when handling Torin-1. It should be used in a controlled laboratory environment, with appropriate personal protective equipment~~. Researchers should be aware of its potential effects and handle it according~~ to ~~established safety guidelines~~.		As with many chemical inhibitors, proper safety protocols should be followed when handling Torin-1. It should be used in a controlled laboratory environment, with appropriate personal protective equipment to minimize exposure.

	== Related Pages ==		== Related Pages ==
Line 26:		Line 28:
	* [[Autophagy]]		* [[Autophagy]]
	* [[Cancer research]]		* [[Cancer research]]
	* [[~~Neurodegenerative diseases~~]]		* [[Protein synthesis]]

	~~== References ==~~

	~~{{Reflist}}~~

	[[Category:Biochemistry]]		[[Category:Biochemistry]]
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:~~Research tools~~]]		[[Category:Cancer research]]

Prab: CSV import

2025-02-09T11:54:50Z

CSV import

← Older revision		Revision as of 11:54, 9 February 2025
Line 1:		Line 1:
	'''Torin-1''' is a potent and selective [[~~mTOR (mechanistic~~ target of rapamycin~~)\|mTOR~~]] ~~inhibitor~~ that is used in biological ~~and medical~~ research~~. It was first identified in a~~ study ~~by Thoreen et al. in 2009, where it was shown to inhibit mTORC1 and mTORC2 with an IC50 of 2 nM and 10 nM, respectively~~.		== Torin-1 ==

			[[File:Torin1_structure.png\|thumb\|Chemical structure of Torin-1]]

			'''Torin-1''' is a potent and selective inhibitor of the [[mammalian target of rapamycin]] (mTOR), a protein kinase that plays a critical role in regulating cell growth, proliferation, and survival. It is widely used in [[biological research]] to study the mTOR signaling pathway.

	== Mechanism of Action ==		== Mechanism of Action ==

	Torin-1 ~~acts by binding to the ATP-binding cleft of~~ mTOR~~, which leads to the inhibition of both [[~~mTORC1]] and [[mTORC2]] complexes. This inhibition ~~results in the dephosphorylation~~ of ~~downstream targets~~, ~~including [[p70S6 Kinase]]~~ and ~~[[4E-BP1]], thereby inhibiting protein synthesis and cell growth~~.		Torin-1 inhibits both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). By targeting these complexes, Torin-1 effectively blocks the downstream signaling pathways that are involved in cell growth and metabolism. This dual inhibition is significant because mTORC1 and mTORC2 regulate different aspects of cellular function, and their combined inhibition can lead to more comprehensive suppression of mTOR signaling.

	== Applications in Research ==		== Applications in Research ==

	~~Due to its potent inhibitory action on mTOR,~~ Torin-1 ~~has been widely~~ used in research to ~~study~~ the role of mTOR ~~signaling~~ in ~~various biological processes~~ and ~~diseases~~. ~~For example, it~~ has been ~~used~~ to ~~investigate the role of mTOR in~~ autophagy, cancer, ~~aging~~, and ~~neurodegeneration~~.		Torin-1 is primarily used in [[cancer research]] to explore the role of mTOR in tumor growth and progression. It has been shown to induce autophagy, a process where cells degrade and recycle their components, which can be beneficial in understanding cancer cell survival mechanisms. Additionally, Torin-1 is used to study [[neurodegenerative diseases]], as mTOR signaling is implicated in the regulation of neuronal survival and function.

			== Synthesis and Chemical Properties ==

	~~== Side Effects~~ and ~~Limitations ==~~		The chemical structure of Torin-1 is characterized by its unique arrangement of atoms that allow it to bind effectively to the mTOR kinase domain. The synthesis of Torin-1 involves multiple steps of organic chemistry, ensuring high specificity and potency. Its chemical properties, such as solubility and stability, make it suitable for use in various experimental conditions.

	While Torin-1 is a powerful tool for research, it is not without its limitations. One of the main concerns is its potential for toxicity, as mTOR plays a crucial role in many normal cellular processes. Additionally, as with any inhibitor, there is the potential for off-target effects.		== Safety and Handling ==

	~~== See Also ==~~		As with many chemical inhibitors, proper safety protocols must be followed when handling Torin-1. It should be used in a controlled laboratory environment, with appropriate personal protective equipment. Researchers should be aware of its potential effects and handle it according to established safety guidelines.

	* [[mTOR]]		== Related Pages ==
	* [[mTORC1]]
	* [[~~mTORC2~~]]		* [[mTOR signaling pathway]]
	* [[Autophagy]]		* [[Autophagy]]
	* [[Cancer]]		* [[Cancer research]]
	* [[~~Aging]]~~		* [[Neurodegenerative diseases]]
	* [[Neurodegeneration]]

	== References ==		== References ==

	~~<references />~~		{{Reflist}}

			[[Category:Biochemistry]]
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:~~Biochemistry~~]]		[[Category:Research tools]]
	~~[[Category:Cell biology]]~~
	~~[[Category:Molecular biology]]~~
	~~[[Category:Signal transduction]]~~

	~~{{pharmacology-stub}}~~

Prab: CSV import

2024-03-08T20:16:00Z

CSV import

New page

'''Torin-1''' is a potent and selective [[mTOR (mechanistic target of rapamycin)|mTOR]] inhibitor that is used in biological and medical research. It was first identified in a study by Thoreen et al. in 2009, where it was shown to inhibit mTORC1 and mTORC2 with an IC50 of 2 nM and 10 nM, respectively.

== Mechanism of Action ==

Torin-1 acts by binding to the ATP-binding cleft of mTOR, which leads to the inhibition of both [[mTORC1]] and [[mTORC2]] complexes. This inhibition results in the dephosphorylation of downstream targets, including [[p70S6 Kinase]] and [[4E-BP1]], thereby inhibiting protein synthesis and cell growth.

== Applications in Research ==

Due to its potent inhibitory action on mTOR, Torin-1 has been widely used in research to study the role of mTOR signaling in various biological processes and diseases. For example, it has been used to investigate the role of mTOR in autophagy, cancer, aging, and neurodegeneration.

== Side Effects and Limitations ==

While Torin-1 is a powerful tool for research, it is not without its limitations. One of the main concerns is its potential for toxicity, as mTOR plays a crucial role in many normal cellular processes. Additionally, as with any inhibitor, there is the potential for off-target effects.

== See Also ==

* [[mTOR]]
* [[mTORC1]]
* [[mTORC2]]
* [[Autophagy]]
* [[Cancer]]
* [[Aging]]
* [[Neurodegeneration]]

== References ==

<references />

[[Category:Pharmacology]]
[[Category:Biochemistry]]
[[Category:Cell biology]]
[[Category:Molecular biology]]
[[Category:Signal transduction]]

{{pharmacology-stub}}